Fatal hypokalemia may occur when severe megaloblastic anemia is treated intensively with vitamin B12, as a result of increased erythrocyte potassium requirements
Among 137 patients with CAD, 44% had a notable endothelial dysfunction characterized by vasoconstriction greater than 20% (71)
At one end of the spectrum, metabolic dysfunction-associated steatotic liver (hepatic steatosis, MASL) may progress to a more advanced state called metabolic dysfunction-associated steatohepatitis (MASH) characterized by significant hepatocyte damage, inflammation, and pericellular fibrosis, and further to cirrhosis (Friedman et al
Optimising metabolic health and reducing systemic inflammation improves tissue repair capacity and enhances the effectiveness of peptide therapy
Studies have also highlighted improved refrigerated stability for Bifidobacterium formulations, underscoring the need for additional in vivo safety data to support broader clinical adoption [54]